I'm not a holder, but OPT did a deal with a group called Carlyle Abbingworth/LaunchTx whereby they stumped up 170mill cash to fund P3 trials, and are then entitled to a % of profits if the product gets to market, (something like 7% of annual sales) capped at 4x their initial investment.. if the trials fail, the debt is wiped.
There would be lots of variations on this kind of arrangement available to NEU, through multiple interested parties I'm guessing. Remember we brought on Jefferies as a strategic advisor last year, we didn't do that for no reason. We're in good hands I'd say, JP and co know what they're sitting on.
NEU Price at posting:
$18.85 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)